Psoriatic Arthritis Treatment Market Report

Psoriatic Arthritis Treatment Market Analysis, Market Size, Therapeutic Class Analysis, Regional Outlook, Competitive Strategies, And Segment Forecasts, 2019 To 2026

  • Published Date: ---
  • Base Year for Estimate:
  • Report ID: GVR5855
  • Format: Electronic (PDF)
  • Historical Data:
  • Number of Pages: 0

The global psoriatic arthritis (PsA) treatment market is projected to exhibit strong growth through the forecast period, driven by the rising disease incidence and emergence of biosimilars. The competition is intensifying with innovator companies demanding stricter legal and regulatory guidelines.

Psoriatic arthritis is a chronic inflammatory condition of the skin and joints that gradually worsens with time. If left untreated, the disease may progress enough to cause permanent joint damage. Epidemiological data from the Arthritis Foundation suggests that more than 60% patients with psoriasis are susceptible to psoriatic arthritis.

The PsA treatment market has been segmented, on the basis of drug classes, into Nonsteroidal Antiinflammatory Drugs (NSAIDs), Disease-modifying Antirheumatic Drugs (DMARDs), and biologics. Among the aforementioned drug classes, biologics capture the largest market share, driven by their targeted mechanism of action and improved efficacy profiles.

The market is further segmented into topicals, orals, and injectables - on the basis of route of administration. Based on sales channel, the market is classified into prescription and Over-the-Counter (OTC) products. Geographically, the market has been divided into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.

Some of the major players in the global psoriatic arthritis treatment market include AbbVie Inc., Amgen Inc., AstraZeneca plc, Bristol-Myers Squibb Company, Celgene Corporation, Eli Lilly and Company, Johnson & Johnson Private Limited, Novartis International AG, Pfizer Inc., and UCB Pharma S.A.

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $4,950
Multi User (2-5) - $5,950
Enterprise Access - $7,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified